Co-Diagnostics Other Share Holders Equity 2017-2024 | CODX

Co-Diagnostics other share holders equity from 2017 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Co-Diagnostics Annual Other Share Holders Equity
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
Co-Diagnostics Quarterly Other Share Holders Equity
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31 $0
2016-12-31
2016-09-30 $0
2016-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical Services $0.034B $0.007B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.604B 11.61
Cencora (COR) United States $48.412B 17.85
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $22.359B 0.00
ICON (ICLR) Ireland $17.552B 15.63
Viatris (VTRS) United States $15.815B 4.87
Avantor (AVTR) United States $13.857B 20.78
Revvity (RVTY) United States $13.522B 23.49
CochLear (CHEOY) Australia $12.586B 0.00
BioMerieux (BMXMF) France $12.119B 0.00
Solventum (SOLV) United States $12.029B 0.00
Medpace Holdings (MEDP) United States $10.624B 29.93
Charles River Laboratories (CRL) United States $9.930B 19.19
HealthEquity (HQY) United States $9.139B 49.60
Doximity (DOCS) United States $8.961B 52.75
Sonic Healthcare (SKHHY) Australia $8.813B 0.00
Bausch + Lomb (BLCO) Canada $6.977B 32.47
Life Times (LTH) United States $5.046B 33.40
Organon (OGN) United States $3.835B 3.87
Sotera Health (SHC) United States $3.515B 18.80
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.968B 33.84
Concentras Parent (CON) United States $2.735B 0.00
PACS (PACS) United States $2.522B 0.00
Alignment Healthcare (ALHC) United States $2.320B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.155B 11.21
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GeneDx Holdings (WGS) United States $1.980B 0.00
Teladoc Health (TDOC) United States $1.791B 0.00
GoodRx Holdings (GDRX) United States $1.635B 42.90
Progyny (PGNY) United States $1.275B 25.81
Pediatrix Medical (MD) United States $1.267B 12.40
CareDx (CDNA) United States $1.211B 0.00
Establishment Labs Holdings (ESTA) $1.193B 0.00
AMN Healthcare Services Inc (AMN) United States $0.978B 6.62
Embecta (EMBC) United States $0.808B 5.38
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.733B 0.00
SBC Medicals (SBC) United States $0.670B 0.00
InnovAge Holding (INNV) United States $0.627B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
DocGo (DCGO) United States $0.420B 15.85
Enhabit (EHAB) United States $0.376B 32.48
COMPASS Pathways (CMPS) United Kingdom $0.304B 0.00
ModivCare (MODV) United States $0.250B 13.54
LifeMD (LFMD) United States $0.246B 0.00
Sera Prognostics (SERA) United States $0.206B 0.00
Biodesix (BDSX) United States $0.175B 0.00
Nutex Health (NUTX) United States $0.173B 0.00
Beauty Health (SKIN) United States $0.173B 0.00
MultiPlan (MPLN) United States $0.114B 0.00
Ascend Wellness Holdings (AAWH) United States $0.094B 0.00
So-Young (SY) China $0.093B 17.98
Singular Genomics Systems (OMIC) United States $0.055B 0.00
OncoCyte (OCX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Pheton Holdings (PTHL) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.022B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00